Case Example: The High-Functioning, High-Serotonin Anxious Type Patient: 35-year-old female executive History of OCD, social anxiety Racing mind, agitation, gut pain, poor sleep Over-reactive to SSRIs, B vitamins, and magnesium glycinate Genetics: MAOA TT (slow) COMT slow MTHFR + DHFR polymorphisms Treatment: B2 (FAD) and NAC to gently support serotonin clearance Magnesium taurate (instead of glycinate) Antioxidants and anti-inflammatories Niacin + taurine to support neurotransmitter modulation Gut repair and low-histamine, anti-inflammatory diet Results: OCD symptoms diminished within 4 weeks, anxiety dropped significantly, and sleep stabilised without medication
This is particularly important for individuals with gastrointestinal disorders, reduced intrinsic factor, or other malabsorption concerns
Patients should be reassured that seeing small bubbles in their GLP-1 pen is normal and not dangerous
One thing that theyre not really considering is some of the nausea is because the medications (slow down) emptying of the GI tract
Injection Technique BPC-157: Localized SubQ BPC-157 works best when injected subcutaneously near the injury site
Linear relationships were observed between AUC 0t and BPC157 doses, as well as between C max and BPC157 doses (Figures 1D,E)